Months after its long-awaited physician assistant program was denied provisional accreditation, California State University, San Bernardino has released a response outlining its concerns with the ...
The Trump administration wants the public to weigh in as it prepares for a review of the federal subsistence program in Alaska, an action that the state’s largest Alaska Native group fears will weaken ...
Egypt and the International Monetary Fund struck a preliminary deal that moves the country closer to clearing two much-awaited program reviews and accessing more of a $8 billion loan. The staff-level ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — A new program ...
AUSTIN (KXAN) – Next year, Texas will be one of six states participating in a Medicare pilot program that uses artificial intelligence to review certain patient service requests to reduce fraud, waste ...
IMF approves Pakistan review, unlocking $1.2 billion Fund cites strong reform implementation despite floods IMF urges prudent policies and faster structural reforms IMF flags need for urgent climate ...
Co-chairs of the Informal Ad Hoc Working Group, H.E. Brian Wallace (Jamaica) and H.E. Carolyn Schwalger (New Zealand) Under-Secretary-General for Policy, Guy Ryder Interventions from members of the ...
As the FDA's Commissioner's National Priority Voucher (CNPV) program has picked up steam, with 15 companies now having secured ultrafast drug reviews, questions and criticisms about the initiative ...
A program allowing Chicago police officers to file charges in low-level gun crimes without first getting approval from a prosecutor will be expanded across the city, Cook County State's Attorney ...
Two obesity drugs are among the six new medications that could get faster FDA review under a new pilot program open to products addressing certain national health priorities. Rare and infectious ...
Editor's note: This article has been updated to provide clarity on a head-to-head study Eli Lilly conducted on its candidate, orforglipron. A pill version under development of Novo Nordisk's (NVO) GLP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results